Cas no 55224-05-0 (Davercin)
Davercin structure
Product Name:Davercin
CAS No:55224-05-0
MF:C38H65NO14
MW:759.921013593674
MDL:MFCD28348360
CID:56717
PubChem ID:10033072
Update Time:2025-04-18
Davercin Chemical and Physical Properties
Names and Identifiers
-
- Davercin
- Erythromycin A cyclic 11,12-carbonate
- (1R,2R,5R,6S,7S,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]heptadecane-4,12,16-trione
- ERYTHROMYCIN CYCLOCARBONATE
- Carbonato ciclico de eritromicina a
- CWE
- Cykliczny weglan erytromycyny a
- Cykliczny weglan erytromycyny A [polish]
- Dravercin
- Eritromicina A carbonato
- Eritromicina A carbonato [spanish]
- Erythromycin A 11,12-carbonate
- Erythromycin cyclic carbonate
- (2R,5R,6S,7S,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-et
- Erythromycin, cyclic 11,12-carbonate
- 4H3125L82R
- CHEMBL4788726
- Erythromycin A cyclic carbonate
- 55224-05-0
- HY-100584
- UNII-4H3125L82R
- (3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyldecahydro-6H-[1,3]dioxolo[4,5-c][1]oxacyclotetradecine-2,6,14(7H)-trione
- CHEBI:135881
- Carbonato ciclico de eritromicina A [Spanish]
- s7550
- ERYTHROMYCIN CYCLOCARBONATE [WHO-DD]
- AKOS037515854
- NCGC00386404-01
- (3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-11-hydroxy-8-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3a,7,9,11,13,15-hexamethyl-tetradecahydro-[1,3]dioxolo[4,5-c]oxacyclotetradecane-2,6,14-trione
- (3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-10-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyloctahy
- (1R,2R,5R,6S,7S,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]heptadecane-4,12,16-trione
- 11054-95-8
- CS-6076
- CCG-270443
- DTXSID801031707
- Q27259580
- cyclic 11,12-erythromycin A carbonate
- Erythromycin Cyclocarbonate?
- DA-52325
- 4H-1,3-Dioxolo[4,5-c]oxacyclotetradecin, erythromycin deriv.; Davercin; Erythromycin A 11,12-carbonate; Erythromycin A cyclic 11,12-carbonate; Erythromycin cyclic carbonate
-
- MDL: MFCD28348360
- Inchi: 1S/C38H65NO14/c1-14-25-38(10)32(52-35(44)53-38)20(4)27(40)18(2)16-36(8,45)31(51-34-28(41)24(39(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-37(9,46-13)30(42)23(7)48-26/h18-26,28-32,34,41-42,45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30+,31-,32-,34+,36-,37-,38-/m1/s1
- InChI Key: NKLGIWNNVDPGCA-ZDYKNUMJSA-N
- SMILES: O([C@H]1[C@@H]([C@H](C[C@@H](C)O1)N(C)C)O)[C@H]1[C@@](C)(C[C@@H](C)C([C@H](C)[C@@H]2[C@@](C)([C@@H](CC)OC([C@H](C)[C@H]([C@@H]1C)O[C@H]1C[C@](C)([C@H]([C@H](C)O1)O)OC)=O)OC(=O)O2)=O)O
Computed Properties
- Exact Mass: 759.44100
- Monoisotopic Mass: 759.441
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 15
- Heavy Atom Count: 53
- Rotatable Bond Count: 7
- Complexity: 1300
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 17
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 189
Experimental Properties
- Color/Form: No data available
- Density: 1.22
- Melting Point: No data available
- Boiling Point: 859.8°C at 760 mmHg
- Flash Point: 473.8±34.3 °C
- Refractive Index: 1.534
- Solubility: 生物體外In Vitro:DMSO溶解度≥ 50 mg/mL(65.80 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
- PSA: 188.98000
- LogP: 2.96780
Davercin Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Safety Instruction: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Davercin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | E650045-2.5mg |
Erythromycin Cyclocarbonate |
55224-05-0 | 2.5mg |
$127.00 | 2023-05-18 | ||
| TRC | E650045-5mg |
Erythromycin Cyclocarbonate |
55224-05-0 | 5mg |
$ 236.00 | 2023-09-07 | ||
| TRC | E650045-25mg |
Erythromycin Cyclocarbonate |
55224-05-0 | 25mg |
$925.00 | 2023-05-18 | ||
| TRC | E650045-100mg |
Erythromycin Cyclocarbonate |
55224-05-0 | 100mg |
$2589.00 | 2023-05-18 | ||
| ChemScence | CS-6076-2mg |
Davercin |
55224-05-0 | >98.0% | 2mg |
$120.0 | 2021-09-02 | |
| ChemScence | CS-6076-5mg |
Davercin |
55224-05-0 | >98.0% | 5mg |
$192.0 | 2021-09-02 | |
| ChemScence | CS-6076-10mg |
Davercin |
55224-05-0 | >98.0% | 10mg |
$312.0 | 2021-09-02 | |
| ChemScence | CS-6076-25mg |
Davercin |
55224-05-0 | >98.0% | 25mg |
$552.0 | 2021-09-02 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci71004-1mg |
Davercin |
55224-05-0 | 98% | 1mg |
¥831.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci71004-5mg |
Davercin |
55224-05-0 | 98% | 5mg |
¥2244.00 | 2022-04-26 |
Davercin Related Literature
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
55224-05-0 (Davercin) Related Products
- 643-22-1(Erythromycin Stearate/Palmitate)
- 7704-67-8(erythromycin thiocyanate)
- 114-07-8(Erythromycin)
- 1675-02-1(Erythromycin,3''-O-demethyl-)
- 3847-29-8(Erythromycin Lactobionate)
- 134-36-1(Erythromycin propionate)
- 81103-11-9(Clarithromycin)
- 1264-62-6(Erythromycin ethylsuccinate)
- 135326-55-5((3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione; (2R,3S,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexanoic acid)
- 26116-56-3(Erythromycylamine)
Recommended suppliers
Jiangsu Xinsu New Materials Co., Ltd
Gold Member
CN Supplier
Bulk
Zhejiang Brunova Technology Co., Ltd.
Gold Member
CN Supplier
Bulk
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
CN Supplier
Reagent
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
CN Supplier
Reagent
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
CN Supplier
Bulk